Neurons enhance blood-brain barrier function via upregulating claudin-5 and VE-cadherin expression due to glial cell line-derived neurotrophic factor secretion.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
30 Oct 2024
Historique:
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

Blood-brain barrier (BBB) prevents neurotoxins from entering central nervous system. We aimed to establish and characterize an

Identifiants

pubmed: 39475379
doi: 10.7554/eLife.96161
pii: 96161
doi:
pii:

Substances chimiques

Claudin-5 0
Cadherins 0
Glial Cell Line-Derived Neurotrophic Factor 0
Antigens, CD 0
cadherin 5 0
CLDN5 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : 82373943
Organisme : National Natural Science Foundation of China
ID : 82173884
Organisme : National Natural Science Foundation of China
ID : 82204511
Organisme : Double First Class University Plan
ID : CPU2022QZ21
Organisme : Jiangsu Funding Program for Excellent Postdoctoral Talent
ID : 2022ZB305
Organisme : China Postdoctoral Science Foundation
ID : 2023M733897
Organisme : Postgraduate Research & Practice Innovation Program of Jiangsu Province
ID : KYCX24_1019

Informations de copyright

© 2024, Yang et al.

Déclaration de conflit d'intérêts

LY, ZL, RM, WW, HZ, XL, HY, LL No competing interests declared

Références

J Neurosci. 2006 Mar 15;26(11):2971-80
pubmed: 16540575
Neurochem Res. 2012 Feb;37(2):401-9
pubmed: 22002662
Int J Mol Sci. 2022 Jul 11;23(14):
pubmed: 35887010
Eur J Pharm Sci. 2018 Oct 15;123:502-514
pubmed: 30098391
Nat Rev Drug Discov. 2016 Apr;15(4):275-92
pubmed: 26794270
Exp Eye Res. 2014 Apr;121:161-7
pubmed: 24594192
Front Cell Neurosci. 2022 Dec 01;16:1065193
pubmed: 36545654
J Cell Sci. 2008 Jul 1;121(Pt 13):2115-22
pubmed: 18565824
Pharm Res. 2014 Dec;31(12):3229-50
pubmed: 25098812
J Pharmacol Exp Ther. 2011 Dec;339(3):935-44
pubmed: 21934030
J Cell Physiol. 2009 Oct;221(1):254-61
pubmed: 19530221
Int J Biol Sci. 2013;9(2):174-89
pubmed: 23412420
Drug Metab Dispos. 2011 Jul;39(7):1270-7
pubmed: 21474681
Biochim Biophys Acta. 2011 Nov;1813(11):1978-86
pubmed: 21440011
J Pharm Pharmacol. 2013 Oct;65(10):1508-17
pubmed: 24028618
Drug Metab Dispos. 2009 May;37(5):946-55
pubmed: 19225039
Development. 2017 Apr 15;144(8):1554-1565
pubmed: 28264837
J Cell Physiol. 2011 Jan;226(1):255-66
pubmed: 20665675
Adv Drug Deliv Rev. 2021 Sep;176:113859
pubmed: 34246710
Fluids Barriers CNS. 2013 Nov 22;10(1):33
pubmed: 24262108
EMBO J. 2005 Mar 23;24(6):1146-56
pubmed: 15775979
Mol Pharm. 2019 May 6;16(5):2069-2082
pubmed: 30916978
Fluids Barriers CNS. 2014 Apr 05;11(1):8
pubmed: 24708805
J Chem Inf Model. 2019 Jul 22;59(7):3251-3261
pubmed: 31260629
Tissue Barriers. 2018;6(4):1-22
pubmed: 30523753
J Pharmacol Exp Ther. 2005 Jun;313(3):1254-62
pubmed: 15743928
J Control Release. 2023 Jun;358:78-97
pubmed: 37076016
Fluids Barriers CNS. 2023 Mar 28;20(1):22
pubmed: 36978081
Exp Neurol. 2022 Jan;347:113867
pubmed: 34582837
Antioxidants (Basel). 2022 Jul 26;11(8):
pubmed: 35892657
Neuroreport. 2000 Apr 7;11(5):1081-4
pubmed: 10790886
Acta Pharmacol Sin. 2020 Nov;42(11):1942-1950
pubmed: 33558655
J Pharm Biomed Anal. 2021 Feb 20;195:113872
pubmed: 33388643
Ann N Y Acad Sci. 1988;529:21-30
pubmed: 3395069
PLoS One. 2016 Jan 08;11(1):e0146692
pubmed: 26745377
Trends Biotechnol. 2018 Apr;36(4):457-472
pubmed: 29422410
Cell Signal. 2018 Aug;48:38-44
pubmed: 29702203
Cell Signal. 2007 Mar;19(3):519-27
pubmed: 17113751
Oncogene. 2000 May 11;19(20):2438-46
pubmed: 10828886
Drug Metab Dispos. 2005 Jan;33(1):175-81
pubmed: 15502010
J Neurosci. 2010 Aug 25;30(34):11403-13
pubmed: 20739562
Mol Pharm. 2013 Jan 7;10(1):289-96
pubmed: 23137377
Mol Pharm. 2019 Nov 4;16(11):4461-4471
pubmed: 31573814
Neurochem Int. 2009 Mar-Apr;54(3-4):253-63
pubmed: 19111869
J Cell Physiol. 2021 Dec;236(12):8184-8196
pubmed: 34170009
Pharmaceutics. 2021 Sep 16;13(9):
pubmed: 34575559
J Inherit Metab Dis. 2013 May;36(3):437-49
pubmed: 23609350
J Pharm Sci. 2017 Dec;106(12):3442-3452
pubmed: 28927987
J Cell Mol Med. 2003 Apr-Jun;7(2):165-70
pubmed: 12927055
Cell Signal. 2016 Aug;28(8):1075-85
pubmed: 27164415
Development. 2020 May 1;147(9):
pubmed: 32358096
Neoplasia. 2018 Jan;20(1):99-117
pubmed: 29245123
Acta Pharm Sin B. 2023 Sep;13(9):3728-3743
pubmed: 37719384
Eur J Pharmacol. 2019 Mar 5;846:119-127
pubmed: 30639310
J Cell Physiol. 2007 Jan;210(1):81-6
pubmed: 16998798
Cell Death Dis. 2022 May 14;13(5):462
pubmed: 35568723
J Chemother. 2013 Dec;25(6):347-54
pubmed: 24090809
Nat Cell Biol. 2008 Aug;10(8):923-34
pubmed: 18604199
Eur J Pharm Biopharm. 2021 Jun;163:120-126
pubmed: 33838261
Biochem Biophys Res Commun. 1999 Jul 22;261(1):108-12
pubmed: 10405331
Nat Rev Cancer. 2020 Jan;20(1):26-41
pubmed: 31601988
Physiol Rev. 2019 Jan 1;99(1):21-78
pubmed: 30280653
Glia. 2010 Jul;58(9):1094-103
pubmed: 20468051
J Pharmacol Exp Ther. 2007 Jul;322(1):205-13
pubmed: 17405866
Acta Physiol (Oxf). 2014 Apr;210(4):790-8
pubmed: 24629161
J Surg Res. 2019 Jun;238:175-185
pubmed: 30771687
Am J Pathol. 2004 May;164(5):1827-35
pubmed: 15111329
Brain Sci. 2021 Jan 08;11(1):
pubmed: 33430164
Pharm Res. 2011 Mar;28(3):517-30
pubmed: 21042838
Drug Metab Dispos. 2011 Mar;39(3):353-62
pubmed: 21149540
Exp Neurol. 2019 Feb;312:72-81
pubmed: 30503192
J Biol Chem. 1999 Jun 11;274(24):16741-6
pubmed: 10358014
Curr Neuropharmacol. 2018;16(9):1375-1384
pubmed: 29473514
Int J Biochem Cell Biol. 2001 Apr;33(4):391-407
pubmed: 11312108
J Cereb Blood Flow Metab. 2020 Feb;40(2):374-391
pubmed: 30574832
Cell Mol Life Sci. 2020 Jun;77(11):2125-2140
pubmed: 31396656
Eur J Neurosci. 1997 Mar;9(3):463-71
pubmed: 9104588
Lung. 2023 Apr;201(2):225-234
pubmed: 36928143
Neuropharmacology. 2013 Sep;72:88-95
pubmed: 23639435
J Cell Biol. 2003 May 12;161(3):653-60
pubmed: 12743111
Drug Metab Dispos. 2012 Oct;40(10):1909-16
pubmed: 22736307
J Cell Mol Med. 2005 Apr-Jun;9(2):373-9
pubmed: 15963256
J Recept Signal Transduct Res. 2018 Aug;38(4):359-366
pubmed: 30481094
J Neurosci Methods. 2011 Aug 15;199(2):223-9
pubmed: 21609734
Nat Rev Endocrinol. 2018 Jan;14(1):25-44
pubmed: 29076504
J Neurosci. 2012 Jan 18;32(3):864-72
pubmed: 22262884
Fluids Barriers CNS. 2013 Mar 26;10(1):16
pubmed: 23531482
Mol Neurobiol. 2016 Dec;53(10):7298-7311
pubmed: 26687235

Auteurs

Lu Yang (L)

Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.

Zijin Lin (Z)

Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.

Ruijing Mu (R)

Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.

Wenhan Wu (W)

Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.

Hao Zhi (H)

Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.

Xiaodong Liu (X)

Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.

Hanyu Yang (H)

Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.

Li Liu (L)

Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH